Changing the course of topical treatment

Zyclara is the next generation of a Aldara, a proven compound in dermatology. This reformulated topical cream provides a significantly more convenient dosing schedule than Aldara but still delivers the efficacy of the parent drug, with excellent tolerability. The campaign speaks to “changing the course” of therapy from a complicated, months-long dosing regimen to a simple 6-week course. The clean, simple graphics feature a road and patients to emphasize the benefits of the short course and the long-term results.

See the Campaign